SCHOOL OF MEDICINE  |  PITT HOME  |  FIND PEOPLE  |  FIND A DOCTOR AT UPMC

Department of Medicine

Department of Medicine

  Division of Hematology/Oncology

News and Events


Recruitment

We are pleased to announce the recruitment of Ronald Buckanovich, MD, PhD and Lan Coffman, MD, PhD to the Division of Hematology-Oncology in the Department of Medicine, to the Division of Gynecology-Oncology in the Department of Obstetrics, Gynecology and Reproductive Science and Magee Womens Research Institute, and to the UPMC Hillman Cancer Center.

   

Ronald Buckanovich, MD, PhD

We are delighted to announce the appointment of Ronald Buckanovich, MD, PhD as Professor of Medicine in the Division of Hematology-Oncology, Professor of Obstetrics, Gynecology and Reproductive Science in the Division of Gynecology-Oncology, Co-Leader of the Breast and Ovarian Cancer Program at the UPMC Hillman Cancer Center, and Co-Director of the UPMC Ovarian Cancer Center of Excellence.  Dr. Buckanovich joined the faculty on September 1, 2017. 
Dr. Buchanovich will play an integral role in the establishment of a Comprehensive Ovarian Biology Research Center at Magee Womens Research Institute and the University of Pittsburgh School of Medicine, which will bring together biology and oncology researchers to study the molecular and physiological factors that mediate the development of ovarian cancer. 

Dr. Buckanovich received his BS in Human Genetics and Biochemistry from Cornell University in 1990. In 1998, he graduated with his MD and PhD degrees from the Cornell, Memorial Sloan Kettering, Rockefeller University Tri-Institutional Medical Scientist training program.  During his graduate training, he worked in the laboratory of Dr. Robert Darnell studying the molecular mechanisms of an ovarian cancer associated autoimmune neurologic disease known as POMA. He then went on to do his training in internal medicine and fellowship training in hematology-medical oncology at the University of Pennsylvania. Following the completion of his fellowship training, he stayed on at the University of Pennsylvania as an Instructor in the Division of Hematology-Oncology for two years, and in 2006, he was recruited to the University of Michigan as Assistant Professor of Obstetrics and Gynecology. Over the next 11 years, he stayed at Michigan and was promoted to Associate Professor with tenure of Internal Medicine and Obstetrics and Gynecology and the Thomas H. Simpson Collegiate Professor.

He is a highly accomplished investigator and is a leading expert in ovarian cancer biology with a specific focus on investigating the role of ovarian cancer stem-like cells and the ovarian cancer niche. At the University of Michigan, he initiated several clinical trials based upon his laboratory studies. His research group has developed two new classes of drugs to be translated for first-in-man clinical trials. Ron’s work has been supported by a variety of peer-reviewed funding mechanisms including multiple grants from the NCI/NIH, a Department of Defense grant, all in the general area of ovarian cancer. He has served as a member of the editorial board for a number of journals including Cancer Research and Journal of Translational Research.

Given his significant accomplishments in the field of ovarian cancer, in the spring of 2017, he was recruited here to Pittsburgh to the Division of Hematology-Oncology of the University of Pittsburgh School of Medicine as Professor of Medicine with a secondary appointment in the Division of Gynecology-Oncology of the Department of Obstetrics, Gynecology and Reproductive Science.

 

Lan Coffman, MD

We are delighted to announce the appointment of Lan Coffman, MD, PhD as Assistant Professor of Medicine in the Division of Hematology-Oncology, Assistant Professor of Obstetrics, Gynecology and Reproductive Science in the Division of Gynecology-Oncology, and member of the Breast and Ovarian Cancer Program at the UPMC Hillman Cancer Center. Dr. Coffman joined the faculty on August 1, 2017.

Dr. Coffman was a member of the MD/PhD Joint Degree Program, and she received her PhD degree in Molecular Medicine in 2008 and her MD degree from the Wake Forest University School of Medicine in Winston-Salem, North Carolina.  She was recruited to the Physician-Scientist Program of the internal medicine residency program at the University of Michigan in Ann Arbor, which she completed in 2012 and then stayed on at Michigan for fellowship training in hematology/oncology.  At the completion of her fellowship in 2016, she was recruited to be clinical lecturer in the Division of Hematology-Oncology. Given her significant research focus in the area of ovarian cancer biology, she was recruited here to Pittsburgh in the winter of 2017 to the Division of Hematology-Oncology of the University of Pittsburgh School of Medicine as Assistant Professor of Medicine with a secondary appointment in the Division of Gynecology-Oncology of the Department of Obstetrics, Gynecology, & Reproductive Medicine.

Dr. Coffman’s research interests are focused on investigating ovarian cancer biology, the ovarian cancer tumor microenvironment, the role of mesenchymal stem cells, and mechanisms of metastasis and the formation of the metastatic microenvironment. In recognition of her research, she has received peer-reviewed funding from the American Cancer Society and the NCI/NIH. Her research laboratory is based in the Magee Womens Research Institute (MWRI) in the Comprehensive Ovarian Biology Research Center. With respect to her clinical interests, Dr. Coffman specializes in the treatment and development of novel agents and treatment regimens for gynecologic malignancies with a particular focus on ovarian cancer.

Please join us in welcoming Drs. Buckanovich and Coffman and their respective families to Pittsburgh.


35th Annual Chemotherapy Foundation Symposium™

Wednesday, November 8, 2017 – Friday, November 10, 2017
New York Marriott Marquis
1535 Broadway, New York, NY 10036

Program Co-Chair

Adam M. Brufsky, MD, PhD
Professor of Medicine
Associate Chief, Division of Hematology/ Oncology
Co-Director, Comprehensive Breast Cancer Center Associate
Director, Clinical Investigation
University of Pittsburgh, Pittsburgh, PA


Now in its 35th year, the Chemotherapy Foundation Symposium™ (CFS™) brings together more than 2000 healthcare professionals, including oncologists, hematologists, radiologists, immunologists, pharmacists, NPs, PAs, and patient advocates, and strives to deliver the latest answers to your clinical challenges. Our internationally renowned faculty will provide expert analysis on the most recent developments in cancer therapies, synthesizing scores of data to provide attendees with the critical distilled information they need. This preeminent 3-day conference provides an unparalleled opportunity to learn new methods of personalizing care for your patients with cancer. Together, we will Innovate Cancer Therapy for Tomorrow®. See you in New York!


Butterfield Addresses Cancer Immunotherapy, Funding in Congressional Briefing
Lisa Butterfield PhD, speaking during a Congressional briefing on Capitol Hill, discussed advances in cancer immunotherapy research as well as the need for continued federal funding.

Photo Provided by American Association for Cancer Research

Dr. Butterfield is a Professor of Medicine, Surgery, Immunology and Clinical and Translational Science—and Director of the UPMC Hillman Cancer Center Immunologic Monitoring and Cellular Products Laboratory—at the University of Pittsburgh School of Medicine. She is also President of the Society for Immunotherapy of Cancer, which co-hosted the briefing in partnership with the American Association for Cancer Research. The event was titled, "Progress in Immunotherapy: Delivering Hope and Clinical Benefit to Cancer Patients."

A leader in cancer immunology research, Dr. Butterfield told the July 19, 2017, briefing audience that stable and increased federal research funding will enable continued advances in the field, as well as support young career scientists in labs performing immunotherapy research.


Kirkwood Is Named a 2017 Giant of Cancer Care
John M. Kirkwood MD has been inducted into the 2017 Giants of Cancer Care recognition program. The honor recognizes healthcare professionals who are advancing the field of oncology through their research and clinical practice. The program is sponsored by OncLive, the official website for the Oncology Specialty Group, which publishes OncologyLive, Urologists in Cancer Care, Oncology Business Management, and Oncology Nursing News.

Dr. Kirkwood is the Usher Professor of Medicine, Dermatology and Translational Science and Director of the Melanoma and Skin Cancer Program, University of Pittsburgh School of Medicine. A renowned researcher in the field of melanoma, he has pioneered the development of cancer immunotherapy for 45 years. Currently, he is developing combinations of new immunotherapies and molecular therapies that are expected to be focus of clinical translational research over the next 10 years.


Eight Physicians from Division of Hematology / Oncology Are Named Best Docs

Eight physicians within the Division of Hematology / Oncology have been named Best Docs, an annual listing of the region's top physicians compiled by Best Doctors Inc. and published by Pittsburgh Magazine.

Listed as 2017 Best Docs in the Medical Oncology and Hematology category were:

Edward Chu MD
Chief, Division of Hematology / Oncology
Professor of Medicine; Interim Director, UPCI

Adam M. Brufsky MD PhD
Associate Chief, Division of Hematology/Oncology
Professor of Medicine

John M. Kirkwood MD
Usher Professor of Medicine, Dermatology and Translational Science

Margaret V. Ragni MD MPH
Professor of Medicine
Director, Hemophilia Center of Western PA

Priya Rastogi MD
Associate Professor of Medicine

Ahmad A. Tarhini MD Phd
Tenured Associate Professor of Medicine, Clinical and Translational Science

Listed as 2017 Best Docs in the Neurology category were:

Jan Drappatz MD
Associate Director, Adult Neuro-Oncology Program
Associate Professor of Neurology and Medicine

Frank S. Lieberman MD
Chief, Adult Neuro-Oncology Service
Associate Professor of Neurology and Medical Oncology
Professor of Neurology

The Best Doctors, Inc.'s database of physicians, and its companion The Best Doctors in America List, are audited and certified by Gallup. An exhaustive peer review determines which physicians are named in the Best Doctors in America database. Only those doctors who earn the support of their peers and who meet other guidelines are included. The entire 2017 list can be found here.